TENAX THERAPEUTICS, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
TENAX THERAPEUTICS, INC. (TENX) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price of $5.72 per share for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-08-09.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice · last filed 2016-08-09
- TENAX THERAPEUTICS, INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2016-03-31 was $0.00.
- TENAX THERAPEUTICS, INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2015-07-31 was $35.09, a 52.15% decline year-over-year.
- TENAX THERAPEUTICS, INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2014-07-31 was $73.34.
- TENAX THERAPEUTICS, INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2012-07-31 was $1.92.
- TENAX THERAPEUTICS, INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2014 was $43.90, a 58.74% decline from fiscal 2013.
- TENAX THERAPEUTICS, INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2013 was $106.40, a 26.97% increase from fiscal 2012.
- TENAX THERAPEUTICS, INC. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2012 was $83.80.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2016-06-30 | $5.72 10-Q · filed 2016-08-09 | |||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-10 | |||
| 2015-10-31 | $35.09 10-Q · filed 2015-12-10 | |||
| 2015-07-31 | $35.09 10-Q · filed 2015-09-09 | |||
| 2015-01-31 | $63.83 10-Q · filed 2015-03-17 | |||
| 2014-10-31 | $73.34 10-Q · filed 2014-12-15 | |||
| 2014-07-31 | $73.34 10-Q · filed 2014-09-15 | |||
| 2014-04-30 | $43.90 10-K · filed 2014-07-29 | |||
| 2014-01-31 | $38.76 10-Q · filed 2014-03-17 | |||
| 2013-10-31 | $38.76 10-Q · filed 2013-12-17 | |||
| 2013-04-30 | $106.40 10-K · filed 2014-07-29 | |||
| 2013-01-31 | $5.42 10-Q · filed 2013-03-18 | |||
| 2012-10-31 | $5.66 10-Q · filed 2012-12-14 | |||
| 2012-07-31 | $1.92 10-Q · filed 2012-09-19 | |||
| 2012-04-30 | $83.80 10-K · filed 2013-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |